Learn About Adenoid Cystic Carcinoma

What is the definition of Adenoid Cystic Carcinoma?
Adenoid cystic carcinoma (ACC) is a rare form of adenocarcinoma, a type of cancer that begins in glandular tissues. It most commonly arises in the major and minor salivary glands of the head and neck. It can also occur in the breast, uterus, or other locations in the body. Symptoms depend on the tumor's location. Salivary gland tumors may cause painless masses in the mouth or face. Tumors of the lacrimal gland may cause a bulging eye or changes in vision. Those affecting the windpipe or voice box may cause respiratory symptoms or changes in speech, respectively. Advanced tumors may cause pain and/or nerve paralysis, as ACC often spreads along the nerves. It may also spread through the bloodstream. It spreads to the lymph nodes in about 5% to 10% of cases. The cause of ACC is currently unknown. It typically does not run in families.
Save information for later
Sign Up
What are the alternative names for Adenoid Cystic Carcinoma?
  • Adenoid cystic carcinoma
  • Adenocystic carcinoma
  • Cribriform carcinoma
  • Cylindroma
Who are the top Adenoid Cystic Carcinoma Local Doctors?
PH
Dr. Patrick K. Ha
Otolaryngology
Elite
Highly rated in
21
conditions
Otolaryngology

University of California San Francisco Health System

Head And Neck Surgery Cancer Clinic

1825 4th St, 
San Francisco, CA 

Patrick Ha is an Otolaryngologist in San Francisco, California. Ha has been practicing medicine for over 24 years and is rated as an Elite expert by MediFind in the treatment of Adenoid Cystic Carcinoma. He is also highly rated in 21 other conditions, according to our data. His top areas of expertise are Adenoid Cystic Carcinoma, Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Tissue Biopsy. Ha is currently accepting new patients.

EH
Dr. Ehab Y. Hanna
Otolaryngology | Surgical Oncology
Elite
Highly rated in
41
conditions
Otolaryngology
Surgical Oncology

University of Texas System

Physicians Referral Service

1515 Holcombe Blvd, 
Houston, TX 

Ehab Hanna is an Otolaryngologist and a Surgical Oncologist in Houston, Texas. Hanna has been practicing medicine for over 41 years and is rated as an Elite expert by MediFind in the treatment of Adenoid Cystic Carcinoma. He is also highly rated in 41 other conditions, according to our data. His top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Adenoid Cystic Carcinoma, Endoscopy, and Laryngectomy. Hanna is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn more
IG
Dr. Ian S. Ganly
Otolaryngology
Elite
Highly rated in
35
conditions
Otolaryngology

Memorial Sloan Kettering Cancer Center

1275 York Ave, 
New York, NY 

Ian Ganly is an Otolaryngologist in New York, New York. Ganly has been practicing medicine for over 34 years and is rated as an Elite expert by MediFind in the treatment of Adenoid Cystic Carcinoma. He is also highly rated in 35 other conditions, according to our data. His top areas of expertise are Thyroid Cancer, Tongue Cancer, Papillary Thyroid Cancer, Laryngectomy, and Tissue Biopsy. Ganly is currently accepting new patients.

View All Doctors
What are the latest Adenoid Cystic Carcinoma Clinical Trials?
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Who is this study for: Adult patients with Rare Cancers
Enrollment Status: Recruiting
Publish Date: February 03, 2023
Intervention Type: Procedure, Biological
Study Drugs: IpilimumabNivolumab
Study Phase: Phase 2

Summary: This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for the following cohorts based on condition: Epithelial tumors of nasal cavi...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1 Study of SGN-B7H4V in Advanced Solid Tumors
Who is this study for: Patients with advanced solid tumors
Enrollment Status: Recruiting
Publish Date: January 25, 2023
Intervention Type: Drug
Study Drug: SGN-B7H4V
Study Phase: Phase 1

Summary: This study will test the safety of a drug called SGN-B7H4V in participants with solid tumors. It will also study the side effects of this drug. A side effect is anything a drug does to the body besides treating the disease. Participants will have cancer that has spread in the body near where it started (locally advanced) and cannot be removed (unresectable) or has spread through the body (metastat...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Adenoid Cystic Carcinoma?
Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck.
Condition: Head and Neck Adenoid Cystic Carcinoma (HNACC)
Journal: Radiation oncology (London, England)
Treatment Used: Postoperative Radiotherapy (PORT)
Number of Patients: 187
Published: December 01, 2022
Underwater endoscopic mucosal resection of upper gastrointestinal subepithelial tumors: A case series pilot study (with video).
Condition: Upper Gastrointestinal Subepithelial Tumors (SETs)
Journal: Medicine
Treatment Used: Underwater Endoscopic Mucosal Resection (UM-EMR)
Number of Patients: 0
Published: October 18, 2022
Tired of the same old research?
Check Latest Advances
Prognosis stratification and postoperative radiation therapy utilization in adenoid cystic carcinoma of the breast.
Condition: Adenoid Cystic Carcinoma of the Breast (ACCB)
Journal: Breast (Edinburgh, Scotland)
Treatment Used: Postoperative Radiation Therapy (RT)
Number of Patients: 689
Published: September 16, 2022
View All Latest Advances